In other studies, NAT has been linked with impaired nutritional status and body composition, and significantly decreased PNI [15, 16], BMI and subcutaneous fat [17], visceral fat [18], and skeletal muscle and visceral and subcutaneous fat [19] in patients with pancreatic cancer. The gene discussed is BRD2; the disease is familial pancreatic carcinoma.